Robert Carter, MD
Internal Medicine · Hinesville, GANPI 1922192418
Payments from drug & device makers
Across 835 payments — averaging $1336.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$655K
- Invivyd Inc$209K
- GSK$135K
- AstraZeneca$57K
- Novo Nordisk AS$56K
- AbbVie$913
- plus $4K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 78 | $654,953 |
| Invivyd Inc | 3 | $209,079 |
| GSK | 44 | $134,932 |
| AstraZeneca | 12 | $56,812 |
| Novo Nordisk AS | 587 | $55,678 |
| AbbVie(2 entities) | 29 | $913 |
| Novo Nordisk | 18 | $852 |
| Seqirus USA Inc | 1 | $682 |
| Merck | 13 | $457 |
| Vanda Pharmaceuticals Inc. | 6 | $335 |
| Amgen | 7 | $281 |
| E.r. Squibb & Sons, L.L.C. | 2 | $173 |
| Indivior Inc. | 9 | $163 |
| Abiomed | 1 | $122 |
| Exact Sciences | 5 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Orexo US, Inc. | 3 | $43 |
| Circassia Inc. | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $27 |
| Braeburn Inc. | 1 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $20 |
| Medtronic | 1 | $18 |
| SK Life Science, Inc. | 1 | $18 |
| Nevro Corp. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
How this compares
$1,115,903 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Hinesville
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.